Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL
Blood
; 140:9900-9901, 2022.
Article
in English
| ScienceDirect | ID: covidwho-2119948
Full text:
Available
Collection:
Databases of international organizations
Database:
ScienceDirect
Topics:
Variants
Language:
English
Journal:
Blood
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS